Five-year follow up of selective laser trabeculoplasty in Chinese eyes

Clinical and Experimental Ophthalmology

Volumn 32, Issue 4, 2004, Pages 368-372

  Lai, Jimmy S M ^a   Chua, John K H ^a   Tham, Clement C Y ^a   Lam, Dennis S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ocular hypertension; Primary open angle glaucoma; Selective laser trabeculoplasty

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DORZOLAMIDE; LATANOPROST; PILOCARPINE;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GONIOSCOPY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; MALE; OPEN ANGLE GLAUCOMA; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TONOMETRY; TRABECULOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD;

EID: 4444348608     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00839.x     Document Type: Article

References (20)

1. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma. Arch Ophthalmol 1979; 97: 319-22.
2. Moriarty AP, McHugh JDA, Spalton DJ, Ffytche TJ, Shah SM, Marshall J. Comparison of the anterior chamber inflammatory response to diode and argon laser trabeculoplasty using a laser flare meter. Ophthalmology 1993; 100: 1263-7.
3. Kwasniewska S, Fankhauser F, Larsen SE, Cruz-Orive LM. The efficacy of cw Nd:YAG laser trabeculoplasty. Ophthalmic Surg 1993; 24: 304-8.
4. Bylsma SB, Samples JR, Acott TS, Van Buskirk EM. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol 1988; 106: 544-7.
5. Rodrigues MM, Spaeth GL, Donohoo P. Electron microscopy of argon laser therapy in phakic open-angle glaucoma. Ophthalmology 1982; 89: 198-210.
6. Fink AI, Jordan AJ, Lao PN, Fong DA. Therapeutic limitations of argon laser trabeculoplasty. Br J Ophthalmol 1988; 72: 263-9.
7. Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch Ophthalmol 1985; 103: 1482-4.
8. Hoskins HD, Hetherington J, Minckler DS, Lieberman MF, Shaffer PN. Complications of laser trabeculoplasty. Ophthalmology 1983; 90: 796-9.
9. Wilensky JT, Weinreb RN. Early and late failures of argon laser trabeculoplasty. Arch Ophthalmol, 1983; 101: 895-7.
10. Rouhiainen HJ, Terasvirta ME, Tuovinen EJ, Peripheral anterior synechiae formation after trabeculoplasty. Arch Ophthalmol 1988; 106: 189-91.
11. Feldman RM, Gross RL, Spaeth GL et al. Risk factors for the development of Tenon's cysts after trabeculoplasty. Ophthalmology 1989; 96: 336-41.
12. Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998; 105: 2082-8.
13. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 1999; 83: 29-32.
14. Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty versus argon laser trabeculoplasty: a prospective randomized clinical trial. Br J Ophthalmol 1999; 83: 718-22.
15. Melamed S, Simon GJB, Lvkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma. A prospective, nonrandomized pilot study. Arch Ophthalmol 2003; 121: 957-60.
16. Latina MA, Park C. Selective targeting of trabecular meshwork cells. in vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995; 60: 359-72.
17. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). I. Acute effects of argon laser trabeculoplasty on intraocular pressure. Arch Ophthalmol 1984; 107: 1135-42.
18. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990; 97: 1401-2.
19. Piltz J, Gross R, Shin DH et al. Contralateral effect of topical β-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study. Am J Ophthalmol 2000; 130: 441-53.
20. Ariturk N, Oge I, Erkan D, Sullu Y, Sahin M. The effects of nasolacrimal canal blockage on topical medications for glaucoma. Acta Ophthalmol Scand 1996; 74: 411-13.